CSL Biotherapies
Rotavirus
Parker & Partners was engaged by CSL Biotherapies to help secure Government funding for a new infant vaccine for rotavirus gastroenteritis, RotaTeq.
The campaign, culminated with a high profile media launch and bi-partisan political briefing at Parliament House in Canberra in February 2007, prompted the Federal Health Minister to commit to a timetable for a vaccine funding decision with the program beginning in July 2007.
The campaign, culminated with a high profile media launch and bi-partisan political briefing at Parliament House in Canberra in February 2007, prompted the Federal Health Minister to commit to a timetable for a vaccine funding decision with the program beginning in July 2007.
Heart Foundation
Through the media, the Heart Foundation's messages reached more than five million people in the first 48 hours following the national launch of the campaign, with four of our free to air news networks covering the story extensively.
The Heart Foundation's inquiry line, Heartline, experienced a 190% increase in calls and equally the Heart Foundation's website had a 600% increase in hits to the specially developed Walk of Life pages.
The Heart Foundation's inquiry line, Heartline, experienced a 190% increase in calls and equally the Heart Foundation's website had a 600% increase in hits to the specially developed Walk of Life pages.
CSL
World's first cervical cancer vaccine
Engaging 100 high profile and influential Australian women was a key component for our campaign for the Australian Government to fund the world's first cervical cancer vaccine.
Following a successful media launch and political engagements, and mounting pressure from the Australian public, in February 2006 it was announced that the vaccine would be funded.
Following a successful media launch and political engagements, and mounting pressure from the Australian public, in February 2006 it was announced that the vaccine would be funded.
CSL
Avian flu
The threat of an avian flu pandemic is one of the most serious health, economic, political and community issues Australia and the region has faced in recent decades.
Parker & Partners, as advisers to CSL Ltd - and their Southern Hemisphere Flu Centre - has successfully managed a series of on-going potential and live issues and crisis threats involving contingency planning, training, rapid response, third parties and major stakeholder engagement.
Parker & Partners, as advisers to CSL Ltd - and their Southern Hemisphere Flu Centre - has successfully managed a series of on-going potential and live issues and crisis threats involving contingency planning, training, rapid response, third parties and major stakeholder engagement.
Amgen
As a part of Amgen's plan to develop relationships with researchers and stakeholder groups in Australia, Amgen committed a $240,000 grant to the Dubbo Osteoporosis Epidemiology Study. Amgen wanted to maximise the public relations around the significant grant and to firmly cement themselves in the osteoporosis space.
Joining with Parker & Partners they were able to achieve this, through thorough media management and an effective event management plan.
Joining with Parker & Partners they were able to achieve this, through thorough media management and an effective event management plan.
Medicines Australia
Parker & Partners has been an adviser to Medicines Australia for many years. Most recently, Parker & Partners was engaged to provide both detailed communications as well as stakeholder management strategies around the Australian Competition Tribunal (ACT) review and pending decision on Medicines Australia’s appeal of an ACCC condition on the industry Code of Conduct.
Parker & Partners developed comprehensive communications strategies and stakeholder analysis which included background, communications plan, pre and post decision tactics and key messaging and a flow chart of decision and response activities. They noted the stakeholder execution element was particularly important given the nature of the ACCC decision and the impact for their members and the industry. Parker & Partners continue to work with Medicines Australia.
Parker & Partners developed comprehensive communications strategies and stakeholder analysis which included background, communications plan, pre and post decision tactics and key messaging and a flow chart of decision and response activities. They noted the stakeholder execution element was particularly important given the nature of the ACCC decision and the impact for their members and the industry. Parker & Partners continue to work with Medicines Australia.